Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for IKZF1
Z-value: 1.85
Motif logo
Transcription factors associated with IKZF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
IKZF1
|
ENSG00000185811.12 | IKAROS family zinc finger 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| IKZF1 | hg19_v2_chr7_+_50344289_50344378 | -0.62 | 1.9e-24 | Click! |
Activity profile of IKZF1 motif
Sorted Z-values of IKZF1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of IKZF1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 17.0 | 136.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 16.0 | 48.0 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 9.5 | 47.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 9.4 | 28.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 8.7 | 52.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 8.6 | 94.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 7.5 | 30.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 7.0 | 7.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 6.9 | 27.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 6.9 | 27.5 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 6.8 | 41.1 | GO:0030421 | defecation(GO:0030421) |
| 6.8 | 27.1 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 6.7 | 20.2 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 6.6 | 26.3 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 6.5 | 32.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 6.5 | 45.6 | GO:0070836 | caveola assembly(GO:0070836) |
| 6.1 | 18.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 6.1 | 55.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 6.0 | 30.1 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 6.0 | 17.9 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 5.8 | 17.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 5.7 | 160.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 5.7 | 5.7 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 5.6 | 5.6 | GO:0007033 | vacuole organization(GO:0007033) |
| 5.6 | 5.6 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 5.5 | 16.4 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
| 5.4 | 10.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 5.3 | 47.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 5.3 | 26.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 5.2 | 26.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 5.1 | 15.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 4.9 | 14.7 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 4.9 | 19.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 4.8 | 62.8 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 4.8 | 19.1 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 4.7 | 23.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 4.6 | 55.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 4.6 | 13.7 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 4.6 | 13.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 4.5 | 13.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 4.5 | 18.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
| 4.5 | 40.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 4.4 | 26.6 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 4.4 | 4.4 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 4.4 | 13.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 4.4 | 47.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 4.3 | 12.9 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 4.3 | 12.9 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 4.2 | 17.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 4.2 | 16.9 | GO:0018032 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 4.2 | 12.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 4.2 | 41.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 4.2 | 33.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 4.1 | 16.5 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
| 4.1 | 16.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 4.0 | 4.0 | GO:0072197 | ureter urothelium development(GO:0072190) ureter morphogenesis(GO:0072197) |
| 4.0 | 20.0 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 4.0 | 23.8 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 4.0 | 15.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 4.0 | 23.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 3.9 | 15.8 | GO:0009956 | radial pattern formation(GO:0009956) |
| 3.9 | 15.6 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 3.9 | 7.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 3.9 | 15.6 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 3.9 | 31.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 3.9 | 15.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 3.8 | 7.6 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 3.8 | 30.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 3.7 | 11.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 3.7 | 18.6 | GO:0030047 | actin modification(GO:0030047) |
| 3.7 | 26.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 3.7 | 14.6 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 3.6 | 18.2 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 3.6 | 10.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 3.6 | 29.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 3.6 | 18.0 | GO:0035803 | egg coat formation(GO:0035803) |
| 3.6 | 10.7 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 3.5 | 24.8 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 3.5 | 10.6 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 3.5 | 10.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 3.5 | 21.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 3.5 | 38.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 3.5 | 3.5 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 3.5 | 10.4 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 3.4 | 20.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 3.4 | 3.4 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
| 3.4 | 30.7 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 3.4 | 40.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 3.4 | 6.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 3.4 | 10.1 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 3.3 | 43.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 3.3 | 3.3 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
| 3.3 | 6.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 3.3 | 13.3 | GO:0072255 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 3.3 | 95.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 3.3 | 3.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 3.3 | 13.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 3.2 | 9.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 3.2 | 16.2 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 3.2 | 9.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 3.2 | 25.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 3.2 | 19.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 3.2 | 9.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 3.2 | 9.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 3.2 | 12.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 3.2 | 19.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 3.2 | 9.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 3.2 | 12.7 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 3.2 | 60.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 3.2 | 12.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 3.2 | 15.8 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 3.1 | 21.9 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 3.1 | 9.3 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 3.1 | 9.3 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 3.1 | 9.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 3.1 | 9.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 3.1 | 3.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 3.0 | 9.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 3.0 | 27.1 | GO:0030091 | protein repair(GO:0030091) |
| 3.0 | 8.9 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 3.0 | 50.5 | GO:0032060 | bleb assembly(GO:0032060) |
| 3.0 | 216.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 2.9 | 8.8 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 2.9 | 23.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 2.9 | 8.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 2.9 | 11.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 2.9 | 5.7 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 2.9 | 31.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 2.9 | 8.6 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 2.8 | 25.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 2.8 | 16.9 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 2.8 | 11.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 2.8 | 11.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 2.8 | 11.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 2.8 | 8.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 2.8 | 16.5 | GO:0007296 | vitellogenesis(GO:0007296) |
| 2.8 | 22.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 2.7 | 8.2 | GO:0007412 | axon target recognition(GO:0007412) |
| 2.7 | 8.2 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 2.7 | 16.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 2.7 | 13.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 2.7 | 16.0 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 2.7 | 10.6 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 2.7 | 13.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 2.6 | 26.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 2.6 | 13.1 | GO:0060356 | leucine import(GO:0060356) |
| 2.6 | 10.5 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 2.6 | 2.6 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 2.6 | 5.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 2.6 | 10.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 2.6 | 18.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 2.6 | 5.1 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
| 2.6 | 2.6 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
| 2.6 | 12.8 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 2.5 | 7.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 2.5 | 17.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 2.5 | 10.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 2.5 | 15.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 2.5 | 17.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 2.5 | 10.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 2.5 | 2.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 2.5 | 17.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 2.5 | 2.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 2.4 | 19.4 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
| 2.4 | 12.1 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 2.4 | 7.2 | GO:0006565 | cysteine biosynthetic process from serine(GO:0006535) L-serine catabolic process(GO:0006565) |
| 2.4 | 7.1 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 2.4 | 21.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 2.4 | 2.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 2.4 | 7.1 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 2.3 | 21.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 2.3 | 14.0 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 2.3 | 2.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 2.3 | 9.3 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 2.3 | 6.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 2.3 | 4.6 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 2.3 | 9.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 2.3 | 34.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 2.3 | 13.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 2.3 | 6.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 2.3 | 70.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 2.3 | 9.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 2.3 | 11.3 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 2.3 | 18.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 2.3 | 2.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 2.2 | 22.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 2.2 | 6.7 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 2.2 | 8.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 2.2 | 6.6 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 2.2 | 6.6 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 2.2 | 6.6 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 2.2 | 6.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 2.2 | 6.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 2.2 | 10.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 2.1 | 34.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 2.1 | 10.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.1 | 6.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 2.1 | 12.9 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 2.1 | 14.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 2.1 | 8.5 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 2.1 | 2.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 2.1 | 8.4 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 2.1 | 6.3 | GO:1902896 | terminal web assembly(GO:1902896) |
| 2.1 | 10.4 | GO:0007619 | courtship behavior(GO:0007619) |
| 2.1 | 2.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 2.1 | 18.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 2.1 | 6.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 2.1 | 6.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 2.1 | 136.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 2.1 | 8.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 2.1 | 10.3 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 2.1 | 2.1 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 2.1 | 22.6 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 2.0 | 8.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 2.0 | 2.0 | GO:2001076 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 2.0 | 38.6 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 2.0 | 10.1 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 2.0 | 6.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 2.0 | 2.0 | GO:0046476 | glucosylceramide biosynthetic process(GO:0006679) glycosylceramide biosynthetic process(GO:0046476) |
| 2.0 | 12.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 2.0 | 6.0 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 2.0 | 2.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
| 2.0 | 6.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 2.0 | 6.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 2.0 | 6.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 2.0 | 3.9 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 2.0 | 3.9 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 2.0 | 13.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 2.0 | 5.9 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 1.9 | 3.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 1.9 | 23.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.9 | 13.6 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.9 | 11.7 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 1.9 | 5.8 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 1.9 | 5.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 1.9 | 5.8 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 1.9 | 3.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 1.9 | 9.5 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 1.9 | 7.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 1.9 | 24.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 1.9 | 5.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.8 | 9.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 1.8 | 29.3 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 1.8 | 3.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 1.8 | 20.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 1.8 | 9.1 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 1.8 | 5.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 1.8 | 16.2 | GO:0009414 | response to water deprivation(GO:0009414) |
| 1.8 | 18.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.8 | 3.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 1.8 | 12.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 1.8 | 1.8 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 1.8 | 12.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 1.8 | 30.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 1.8 | 8.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.7 | 50.5 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 1.7 | 1.7 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 1.7 | 29.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 1.7 | 6.9 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 1.7 | 5.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 1.7 | 1.7 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 1.7 | 8.6 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.7 | 10.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 1.7 | 6.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 1.7 | 6.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 1.7 | 20.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 1.7 | 6.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.7 | 20.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 1.7 | 6.7 | GO:0032218 | riboflavin transport(GO:0032218) |
| 1.7 | 1.7 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.7 | 3.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.7 | 6.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.7 | 10.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 1.7 | 5.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 1.7 | 3.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 1.7 | 6.6 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 1.6 | 3.3 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 1.6 | 31.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.6 | 6.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 1.6 | 6.6 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.6 | 1.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 1.6 | 4.9 | GO:0014028 | notochord formation(GO:0014028) |
| 1.6 | 3.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.6 | 3.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.6 | 6.5 | GO:0021564 | vagus nerve development(GO:0021564) |
| 1.6 | 6.5 | GO:0042262 | DNA protection(GO:0042262) |
| 1.6 | 6.4 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.6 | 4.8 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.6 | 1.6 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 1.6 | 3.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 1.6 | 11.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 1.6 | 14.1 | GO:0042407 | cristae formation(GO:0042407) |
| 1.6 | 3.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 1.6 | 32.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 1.6 | 1.6 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 1.6 | 14.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 1.6 | 9.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 1.5 | 12.4 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 1.5 | 4.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 1.5 | 15.3 | GO:0060056 | mammary gland involution(GO:0060056) |
| 1.5 | 4.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 1.5 | 6.0 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 1.5 | 6.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.5 | 13.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.5 | 3.0 | GO:1901656 | glycoside transport(GO:1901656) |
| 1.5 | 1.5 | GO:0071029 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 1.5 | 7.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 1.5 | 10.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.5 | 4.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 1.5 | 1.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 1.5 | 2.9 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.5 | 5.8 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 1.5 | 16.0 | GO:0043248 | proteasome assembly(GO:0043248) |
| 1.5 | 24.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 1.4 | 5.8 | GO:0048254 | snoRNA localization(GO:0048254) |
| 1.4 | 20.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
| 1.4 | 33.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 1.4 | 22.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 1.4 | 2.9 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 1.4 | 4.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 1.4 | 2.8 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
| 1.4 | 22.5 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 1.4 | 5.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 1.4 | 11.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 1.4 | 4.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) GDP-L-fucose metabolic process(GO:0046368) |
| 1.4 | 1.4 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 1.4 | 7.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.4 | 4.2 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.4 | 11.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 1.4 | 66.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 1.4 | 6.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 1.4 | 1.4 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 1.4 | 1.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 1.4 | 6.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 1.4 | 5.4 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 1.3 | 9.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.3 | 2.7 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
| 1.3 | 8.0 | GO:1904044 | response to aldosterone(GO:1904044) |
| 1.3 | 6.7 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) |
| 1.3 | 54.3 | GO:0035329 | hippo signaling(GO:0035329) |
| 1.3 | 7.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 1.3 | 4.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 1.3 | 3.9 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 1.3 | 3.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 1.3 | 2.6 | GO:0002009 | morphogenesis of an epithelium(GO:0002009) |
| 1.3 | 1.3 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.3 | 5.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.3 | 1.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
| 1.3 | 1.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 1.3 | 5.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 1.3 | 3.9 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
| 1.3 | 3.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.3 | 5.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 1.3 | 14.0 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.3 | 2.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 1.3 | 16.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 1.3 | 1.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 1.3 | 17.8 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 1.3 | 16.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 1.3 | 5.0 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 1.3 | 5.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 1.2 | 3.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 1.2 | 8.7 | GO:0046618 | drug export(GO:0046618) |
| 1.2 | 7.4 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
| 1.2 | 3.7 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.2 | 3.7 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 1.2 | 2.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 1.2 | 1.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 1.2 | 13.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 1.2 | 45.2 | GO:0018208 | protein peptidyl-prolyl isomerization(GO:0000413) peptidyl-proline modification(GO:0018208) |
| 1.2 | 6.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 1.2 | 1.2 | GO:0042391 | regulation of membrane potential(GO:0042391) |
| 1.2 | 3.6 | GO:2000232 | positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
| 1.2 | 32.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 1.2 | 6.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.2 | 6.0 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 1.2 | 2.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 1.2 | 53.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 1.2 | 5.9 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 1.2 | 120.6 | GO:0070268 | cornification(GO:0070268) |
| 1.2 | 3.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
| 1.2 | 2.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 1.2 | 18.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 1.2 | 5.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 1.2 | 3.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.2 | 11.7 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.2 | 1.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.2 | 2.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.2 | 1.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 1.2 | 3.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 1.2 | 12.8 | GO:0006108 | malate metabolic process(GO:0006108) |
| 1.2 | 2.3 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.2 | 3.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.2 | 10.5 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 1.2 | 3.5 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 1.1 | 3.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 1.1 | 20.7 | GO:0031639 | plasminogen activation(GO:0031639) |
| 1.1 | 3.4 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 1.1 | 20.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 1.1 | 4.6 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 1.1 | 4.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 1.1 | 3.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 1.1 | 2.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 1.1 | 1.1 | GO:0021612 | facial nerve structural organization(GO:0021612) |
| 1.1 | 4.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 1.1 | 3.4 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 1.1 | 3.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 1.1 | 1.1 | GO:0048819 | hair cycle phase(GO:0044851) regulation of hair follicle maturation(GO:0048819) |
| 1.1 | 26.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.1 | 3.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 1.1 | 36.0 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 1.1 | 8.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 1.1 | 9.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 1.1 | 4.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.1 | 2.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 1.1 | 3.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
| 1.1 | 19.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.1 | 10.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 1.1 | 6.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 1.1 | 2.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 1.1 | 5.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 1.1 | 5.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.1 | 1.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 1.1 | 2.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 1.1 | 6.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 1.0 | 5.2 | GO:1990834 | response to odorant(GO:1990834) |
| 1.0 | 29.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 1.0 | 9.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 1.0 | 9.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 1.0 | 5.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.0 | 1.0 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 1.0 | 4.2 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 1.0 | 4.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 1.0 | 16.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 1.0 | 3.1 | GO:0018158 | protein oxidation(GO:0018158) |
| 1.0 | 3.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 1.0 | 8.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 1.0 | 1.0 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 1.0 | 3.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.0 | 3.1 | GO:0034475 | U4 snRNA 3'-end processing(GO:0034475) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 1.0 | 1.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 1.0 | 15.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 1.0 | 18.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 1.0 | 4.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.0 | 6.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 1.0 | 3.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 1.0 | 20.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 1.0 | 6.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 1.0 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 1.0 | 2.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
| 1.0 | 1.0 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 1.0 | 8.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.0 | 3.0 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.0 | 9.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 1.0 | 5.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 1.0 | 1.0 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 1.0 | 11.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 1.0 | 2.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 1.0 | 3.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 1.0 | 2.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.0 | 1.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 1.0 | 3.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.0 | 6.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 1.0 | 4.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.0 | 2.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.0 | 1.9 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 1.0 | 15.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 1.0 | 2.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 1.0 | 25.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 1.0 | 3.8 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 1.0 | 1.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 1.0 | 5.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.9 | 39.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.9 | 2.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.9 | 5.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.9 | 7.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.9 | 13.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.9 | 10.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.9 | 1.8 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.9 | 12.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.9 | 3.7 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) |
| 0.9 | 1.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.9 | 4.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.9 | 2.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 0.9 | 2.7 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.9 | 1.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.9 | 7.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.9 | 26.3 | GO:0097435 | fibril organization(GO:0097435) |
| 0.9 | 14.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.9 | 7.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.9 | 5.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.9 | 7.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.9 | 6.3 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.9 | 8.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.9 | 4.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.9 | 27.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.9 | 1.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.9 | 25.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.9 | 7.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.9 | 3.5 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.9 | 5.2 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
| 0.9 | 4.4 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 0.9 | 0.9 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
| 0.9 | 2.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.9 | 0.9 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.9 | 3.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.9 | 19.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.9 | 1.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.9 | 2.6 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.9 | 1.7 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.9 | 9.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.9 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.9 | 2.6 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) |
| 0.8 | 56.9 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 0.8 | 4.2 | GO:0015862 | uridine transport(GO:0015862) |
| 0.8 | 2.5 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.8 | 5.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.8 | 21.9 | GO:0019430 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.8 | 8.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.8 | 5.9 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.8 | 6.7 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.8 | 1.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.8 | 3.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.8 | 0.8 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.8 | 3.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.8 | 0.8 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
| 0.8 | 1.7 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.8 | 0.8 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.8 | 6.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.8 | 0.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.8 | 5.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.8 | 7.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.8 | 60.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.8 | 2.4 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.8 | 2.4 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.8 | 8.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.8 | 8.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.8 | 3.2 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.8 | 4.0 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.8 | 4.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.8 | 9.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.8 | 4.7 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.8 | 6.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.8 | 1.6 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.8 | 1.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.8 | 6.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.8 | 1.5 | GO:0046070 | dGTP metabolic process(GO:0046070) |
| 0.8 | 3.9 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.8 | 2.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 | 7.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.8 | 0.8 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.8 | 3.8 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.8 | 1.5 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.8 | 3.8 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.8 | 1.5 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.8 | 4.5 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
| 0.8 | 2.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.8 | 3.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.8 | 4.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.8 | 6.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.8 | 2.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.7 | 3.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.7 | 2.2 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.7 | 3.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.7 | 11.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.7 | 2.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.7 | 4.5 | GO:0015853 | adenine transport(GO:0015853) |
| 0.7 | 2.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
| 0.7 | 6.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.7 | 5.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.7 | 3.7 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 0.7 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.7 | 2.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.7 | 6.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.7 | 5.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.7 | 0.7 | GO:0031081 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 0.7 | 3.6 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.7 | 5.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.7 | 4.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.7 | 5.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.7 | 2.2 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.7 | 1.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.7 | 2.9 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.7 | 2.9 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.7 | 8.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.7 | 2.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.7 | 3.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.7 | 2.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.7 | 5.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.7 | 4.9 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.7 | 15.5 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.7 | 1.4 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
| 0.7 | 4.2 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.7 | 2.8 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
| 0.7 | 2.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.7 | 0.7 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.7 | 4.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.7 | 4.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.7 | 1.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.7 | 1.4 | GO:0006266 | DNA ligation(GO:0006266) |
| 0.7 | 6.9 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.7 | 1.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.7 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.7 | 4.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.7 | 1.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.7 | 6.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.7 | 12.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.7 | 3.4 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.7 | 7.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.7 | 28.2 | GO:0043486 | histone exchange(GO:0043486) |
| 0.7 | 3.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.7 | 1.3 | GO:0009209 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
| 0.7 | 3.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.7 | 2.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.7 | 0.7 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.7 | 15.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.7 | 2.6 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.7 | 2.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.6 | 1.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.6 | 4.5 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.6 | 5.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.6 | 20.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.6 | 11.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.6 | 4.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.6 | 5.7 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.6 | 5.7 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.6 | 3.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.6 | 8.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.6 | 12.6 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.6 | 1.9 | GO:0009597 | detection of virus(GO:0009597) |
| 0.6 | 0.6 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.6 | 1.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.6 | 7.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.6 | 3.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.6 | 2.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.6 | 1.2 | GO:0045829 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.6 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.6 | 3.1 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 0.6 | 1.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.6 | 3.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 0.6 | 1.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.6 | 1.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.6 | 6.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.6 | 0.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.6 | 6.7 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.6 | 1.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.6 | 6.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.6 | 23.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.6 | 1.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.6 | 1.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.6 | 4.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.6 | 0.6 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 0.6 | 1.2 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.6 | 2.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.6 | 11.8 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.6 | 4.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.6 | 2.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.6 | 7.1 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.6 | 1.2 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.6 | 1.8 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
| 0.6 | 1.8 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.6 | 1.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.6 | 1.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.6 | 1.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.6 | 0.6 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.6 | 0.6 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.6 | 2.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.6 | 4.0 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.6 | 1.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.6 | 1.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.6 | 1.7 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.6 | 2.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.6 | 4.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.6 | 0.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.6 | 1.1 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.6 | 2.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.6 | 2.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.6 | 2.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.6 | 1.1 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.6 | 2.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.6 | 2.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
| 0.6 | 4.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.6 | 1.7 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.6 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.6 | 1.7 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.6 | 1.1 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.6 | 1.1 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
| 0.6 | 3.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.6 | 2.2 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 0.5 | 13.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.5 | 2.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 | 3.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.5 | 7.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.5 | 4.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.5 | 1.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.5 | 1.1 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.5 | 8.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.5 | 1.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.5 | 1.6 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.5 | 1.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.5 | 2.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.5 | 2.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.5 | 3.7 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 0.5 | 1.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.5 | 2.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.5 | 12.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.5 | 2.6 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.5 | 5.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.5 | 4.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.5 | 2.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.5 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.5 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 1.0 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.5 | 2.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.5 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.5 | 1.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.5 | 9.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.5 | 1.0 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.5 | 3.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.5 | 3.1 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.5 | 8.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.5 | 5.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.5 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.5 | 7.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 0.5 | 1.0 | GO:0061724 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.5 | 4.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.5 | 2.0 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
| 0.5 | 4.0 | GO:0060065 | uterus development(GO:0060065) |
| 0.5 | 2.0 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.5 | 5.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.5 | 1.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.5 | 1.0 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.5 | 1.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.5 | 34.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.5 | 1.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.5 | 31.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.5 | 1.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.5 | 2.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.5 | 2.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.5 | 0.5 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.5 | 3.4 | GO:0043542 | endothelial cell migration(GO:0043542) |
| 0.5 | 0.5 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 0.5 | 1.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.5 | 0.5 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.5 | 2.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.5 | 1.4 | GO:0009415 | response to water(GO:0009415) |
| 0.5 | 14.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.5 | 1.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.5 | 2.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.5 | 1.9 | GO:0036376 | sodium ion export from cell(GO:0036376) |
| 0.5 | 5.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.5 | 1.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.5 | 0.9 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.5 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.5 | 1.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.5 | 0.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.5 | 0.9 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
| 0.5 | 12.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.5 | 0.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.5 | 2.8 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.5 | 4.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.5 | 2.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.5 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.5 | 4.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.5 | 4.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.5 | 0.5 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.5 | 24.9 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.5 | 1.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.5 | 1.8 | GO:0010193 | response to ozone(GO:0010193) |
| 0.5 | 0.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.5 | 1.8 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 0.4 | 6.7 | GO:0031424 | keratinization(GO:0031424) |
| 0.4 | 2.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.4 | 1.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.4 | 3.6 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.4 | 0.9 | GO:0052314 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
| 0.4 | 1.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.4 | 4.0 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.4 | 1.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.4 | 2.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.4 | 1.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.4 | 5.7 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.4 | 2.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.4 | 2.6 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.4 | 3.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.4 | 1.8 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.4 | 2.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 | 2.6 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.4 | 0.4 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
| 0.4 | 5.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.4 | 3.9 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.4 | 1.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 | 1.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.4 | 4.3 | GO:0030048 | actin filament-based movement(GO:0030048) |
| 0.4 | 1.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.4 | 13.3 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.4 | 0.4 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.4 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.4 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.4 | 0.4 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.4 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.4 | 2.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.4 | 5.9 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.4 | 1.7 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.4 | 5.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.4 | 4.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.4 | 1.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.4 | 9.6 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.4 | 5.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.4 | 1.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.4 | 0.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.4 | 0.8 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.4 | 0.8 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
| 0.4 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.4 | 1.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.4 | 1.6 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
| 0.4 | 4.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.4 | 10.6 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.4 | 27.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.4 | 8.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.4 | 1.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.4 | 4.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 6.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.4 | 1.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.4 | 1.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.4 | 2.8 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.4 | 1.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.4 | 2.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.4 | 2.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.4 | 1.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.4 | 1.2 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 | 3.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.4 | 3.6 | GO:0042026 | protein refolding(GO:0042026) |
| 0.4 | 2.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.4 | 2.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.4 | 3.1 | GO:0006751 | glutathione catabolic process(GO:0006751) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.4 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.4 | 1.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.4 | 8.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.4 | 0.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.4 | 2.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.4 | 11.9 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.4 | 1.5 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.4 | 1.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.4 | 0.8 | GO:0003209 | cardiac atrium morphogenesis(GO:0003209) |
| 0.4 | 23.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.4 | 0.4 | GO:0090244 | trachea cartilage morphogenesis(GO:0060535) Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.4 | 1.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 | 1.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.4 | 2.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.4 | 3.4 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
| 0.4 | 1.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.4 | 6.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.4 | 0.4 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.4 | 1.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.4 | 1.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.4 | 1.9 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.4 | 1.5 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 | 2.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.4 | 4.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.4 | 1.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 | 1.5 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.4 | 4.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 | 0.4 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.4 | 0.7 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.4 | 4.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.4 | 1.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.4 | 1.8 | GO:1902739 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.4 | 6.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.3 | 1.7 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 | 0.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.3 | 1.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.3 | 1.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.3 | 1.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 | 2.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.3 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.3 | 1.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.3 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.3 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.3 | 1.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.3 | 0.7 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.3 | 0.7 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.3 | 1.0 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.3 | 3.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 | 1.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 | 4.3 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 0.3 | 4.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.3 | 1.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.3 | 0.3 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.3 | 1.0 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.3 | 2.0 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.3 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.3 | 1.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.3 | 0.6 | GO:0061053 | somite development(GO:0061053) |
| 0.3 | 2.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 1.9 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.3 | 1.3 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 | 1.9 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.3 | 0.6 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.3 | 4.7 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.3 | 6.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 | 5.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 | 0.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.3 | 1.2 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
| 0.3 | 1.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 6.5 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.3 | 5.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.3 | 0.6 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.3 | 1.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.3 | 1.5 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
| 0.3 | 14.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.3 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 | 2.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 | 0.9 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
| 0.3 | 9.9 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.3 | 6.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.3 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.3 | 16.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.3 | 0.3 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.3 | 0.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.3 | 0.9 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
| 0.3 | 1.5 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.3 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 | 0.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.3 | 1.2 | GO:0007350 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.3 | 2.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.3 | 2.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.3 | 0.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.3 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.3 | 1.4 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) |
| 0.3 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.3 | 1.1 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.3 | 1.4 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.3 | 0.3 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
| 0.3 | 1.7 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
| 0.3 | 0.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.3 | 2.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 | 0.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.3 | 0.8 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.3 | 0.8 | GO:0060416 | response to growth hormone(GO:0060416) |
| 0.3 | 0.3 | GO:0038001 | paracrine signaling(GO:0038001) |
| 0.3 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.3 | 0.8 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.3 | 6.2 | GO:0035904 | aorta development(GO:0035904) |
| 0.3 | 2.7 | GO:0001783 | B cell apoptotic process(GO:0001783) |
| 0.3 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.3 | 1.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.3 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 | 33.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.3 | 1.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.3 | 0.8 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
| 0.3 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 | 1.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.3 | 0.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.3 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 | 1.5 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.3 | 4.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.3 | 4.0 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.3 | 1.3 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.3 | 3.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.3 | 4.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.3 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 7.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 0.2 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.2 | 2.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 3.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.2 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 0.7 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.2 | 1.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.2 | 4.1 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.2 | 1.1 | GO:0021902 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 | 2.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.2 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.2 | 0.7 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
| 0.2 | 1.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 | 4.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.2 | 0.4 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
| 0.2 | 0.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.2 | 0.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.2 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.2 | 0.2 | GO:0003018 | vascular process in circulatory system(GO:0003018) regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
| 0.2 | 3.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.2 | 0.6 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.2 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 3.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 | 1.5 | GO:0048538 | thymus development(GO:0048538) |
| 0.2 | 0.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
| 0.2 | 0.4 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.2 | 2.1 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
| 0.2 | 1.9 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.2 | 1.1 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.2 | 24.8 | GO:0006457 | protein folding(GO:0006457) |
| 0.2 | 21.5 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.2 | 2.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 0.8 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 0.8 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 0.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.2 | 0.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.2 | 1.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.2 | 0.2 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 1.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.2 | 1.4 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.2 | 0.6 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.2 | 0.4 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.2 | 0.2 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.2 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 0.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 | 4.6 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.2 | 0.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.2 | 3.8 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.2 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 1.7 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 | 0.7 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.2 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.2 | 8.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.2 | 1.6 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.2 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.2 | 0.4 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.2 | 0.7 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 | 0.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.2 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.2 | 1.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.2 | 0.7 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.2 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 | 1.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.2 | 0.3 | GO:0042168 | heme metabolic process(GO:0042168) |
| 0.2 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.2 | 1.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.2 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.2 | 0.3 | GO:0040013 | negative regulation of locomotion(GO:0040013) |
| 0.2 | 1.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.2 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 1.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.2 | 0.8 | GO:0010878 | cholesterol storage(GO:0010878) regulation of cholesterol storage(GO:0010885) |
| 0.2 | 0.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.2 | 1.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 | 1.6 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.2 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 2.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.1 | 0.1 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.1 | 0.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 1.9 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 | 2.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 2.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.1 | 0.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
| 0.1 | 0.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) regulation of angiotensin levels in blood(GO:0002002) angiotensin maturation(GO:0002003) regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 | 2.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 2.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.1 | 0.1 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.3 | GO:0051403 | stress-activated MAPK cascade(GO:0051403) |
| 0.1 | 0.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.1 | 3.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.1 | 0.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 0.8 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.4 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 2.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.8 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.1 | 0.2 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 | 1.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.1 | 0.6 | GO:0008344 | adult locomotory behavior(GO:0008344) |
| 0.1 | 1.5 | GO:0006415 | translational termination(GO:0006415) |
| 0.1 | 0.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 | 0.7 | GO:0010935 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
| 0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.6 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 | 0.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 0.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.1 | 0.8 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 | 0.7 | GO:0006833 | water transport(GO:0006833) |
| 0.1 | 0.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.6 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.1 | 2.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 0.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 | 0.8 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.1 | 3.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 4.6 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.1 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.8 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.5 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.1 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.1 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.1 | GO:0015820 | leucine transport(GO:0015820) |
| 0.1 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 1.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 1.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 0.4 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.1 | 0.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.1 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 | 0.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.6 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.1 | 0.4 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.1 | 6.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.1 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 1.4 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 19.4 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.1 | 0.2 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 0.9 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 | 0.1 | GO:0031497 | chromatin assembly(GO:0031497) |
| 0.1 | 0.5 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 0.1 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 0.5 | GO:1903203 | regulation of oxidative stress-induced neuron death(GO:1903203) |
| 0.1 | 0.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.1 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
| 0.1 | 0.8 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.1 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 | 0.1 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.1 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 0.1 | 0.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 0.1 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
| 0.0 | 0.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.0 | 0.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.0 | 0.2 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
| 0.0 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
| 0.0 | 0.3 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) |
| 0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.1 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
| 0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 | 0.3 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.0 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
| 0.0 | 0.1 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.0 | 0.5 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
| 0.0 | 0.1 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
| 0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.0 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.0 | 0.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 | 0.0 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.0 | 2.0 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
| 0.0 | 0.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 1.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 | 0.1 | GO:1900542 | regulation of purine nucleotide metabolic process(GO:1900542) |
| 0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.1 | GO:0090659 | walking behavior(GO:0090659) |
| 0.0 | 0.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.0 | 0.0 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 | 0.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.0 | 0.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.0 | 0.1 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 0.0 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.0 | 0.1 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.0 | 0.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.0 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 | 0.0 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
| 0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.0 | 55.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 8.8 | 167.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 6.1 | 18.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 6.1 | 73.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 5.5 | 33.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 4.5 | 13.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 4.4 | 70.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 4.4 | 26.4 | GO:1990357 | terminal web(GO:1990357) |
| 4.4 | 13.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 4.4 | 34.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 4.2 | 12.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 4.2 | 21.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 4.2 | 12.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 4.0 | 8.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 4.0 | 19.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 3.9 | 39.4 | GO:0097255 | R2TP complex(GO:0097255) |
| 3.8 | 57.5 | GO:0005916 | fascia adherens(GO:0005916) |
| 3.8 | 30.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 3.8 | 18.9 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 3.7 | 18.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 3.7 | 43.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 3.6 | 3.6 | GO:0043256 | laminin complex(GO:0043256) |
| 3.5 | 10.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 3.4 | 47.9 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 3.4 | 13.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 3.3 | 20.0 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 3.3 | 90.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 3.3 | 16.4 | GO:0001940 | male pronucleus(GO:0001940) |
| 3.3 | 29.3 | GO:0005638 | lamin filament(GO:0005638) |
| 3.1 | 59.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 3.1 | 34.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 3.0 | 24.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 3.0 | 21.1 | GO:0016272 | prefoldin complex(GO:0016272) |
| 3.0 | 21.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 3.0 | 3.0 | GO:0000811 | GINS complex(GO:0000811) |
| 2.9 | 8.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 2.9 | 52.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 2.9 | 8.8 | GO:0044393 | microspike(GO:0044393) |
| 2.9 | 29.0 | GO:0034709 | methylosome(GO:0034709) |
| 2.9 | 120.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 2.8 | 50.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 2.8 | 8.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 2.8 | 16.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 2.7 | 21.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 2.7 | 48.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 2.6 | 119.1 | GO:0045095 | keratin filament(GO:0045095) |
| 2.6 | 20.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 2.6 | 10.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 2.4 | 14.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 2.4 | 19.4 | GO:0070552 | BRISC complex(GO:0070552) |
| 2.4 | 7.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 2.4 | 7.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 2.4 | 2.4 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 2.4 | 16.9 | GO:0061617 | MICOS complex(GO:0061617) |
| 2.3 | 25.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 2.3 | 14.0 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 2.3 | 4.7 | GO:0045180 | basal cortex(GO:0045180) |
| 2.3 | 23.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 2.3 | 9.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 2.3 | 15.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 2.3 | 11.3 | GO:0071986 | Ragulator complex(GO:0071986) |
| 2.2 | 6.7 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 2.2 | 8.8 | GO:1990423 | RZZ complex(GO:1990423) |
| 2.2 | 30.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 2.2 | 6.6 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 2.2 | 21.9 | GO:0005915 | zonula adherens(GO:0005915) |
| 2.2 | 10.9 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 2.2 | 141.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 2.1 | 6.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 2.1 | 2.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 2.1 | 27.6 | GO:0097470 | ribbon synapse(GO:0097470) |
| 2.1 | 35.8 | GO:0042583 | chromaffin granule(GO:0042583) |
| 2.1 | 14.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 2.1 | 37.3 | GO:0005861 | troponin complex(GO:0005861) |
| 2.1 | 8.3 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 2.1 | 18.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 2.0 | 30.6 | GO:0090543 | Flemming body(GO:0090543) |
| 2.0 | 12.0 | GO:0070545 | PeBoW complex(GO:0070545) |
| 2.0 | 6.0 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 2.0 | 9.9 | GO:1990393 | 3M complex(GO:1990393) |
| 2.0 | 33.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 2.0 | 13.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 2.0 | 5.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 1.9 | 7.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 1.9 | 36.1 | GO:0001726 | ruffle(GO:0001726) |
| 1.8 | 1.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 1.8 | 7.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 1.8 | 10.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 1.8 | 18.1 | GO:0001739 | sex chromatin(GO:0001739) |
| 1.8 | 7.2 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 1.8 | 14.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.8 | 14.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 1.8 | 63.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 1.7 | 19.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.7 | 11.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 1.7 | 20.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 1.7 | 42.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.7 | 8.4 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.7 | 37.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.7 | 18.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.7 | 5.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 1.7 | 13.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 1.7 | 57.9 | GO:0032420 | stereocilium(GO:0032420) |
| 1.6 | 18.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.6 | 9.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 1.6 | 13.1 | GO:0097449 | astrocyte projection(GO:0097449) |
| 1.6 | 61.7 | GO:0031430 | M band(GO:0031430) |
| 1.6 | 14.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 1.6 | 11.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 1.6 | 38.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 1.6 | 4.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.6 | 11.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 1.6 | 6.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 1.6 | 6.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 1.6 | 9.4 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 1.6 | 7.8 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 1.6 | 9.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 1.5 | 31.0 | GO:0030056 | hemidesmosome(GO:0030056) |
| 1.5 | 19.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 1.5 | 19.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 1.5 | 10.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 1.5 | 22.7 | GO:0005869 | dynactin complex(GO:0005869) |
| 1.5 | 7.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 1.5 | 1.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 1.5 | 8.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 1.5 | 10.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 1.4 | 7.2 | GO:0097513 | myosin II filament(GO:0097513) |
| 1.4 | 5.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 1.4 | 12.6 | GO:0070938 | contractile ring(GO:0070938) |
| 1.4 | 22.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 1.4 | 15.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 1.4 | 13.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.4 | 66.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 1.4 | 27.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 1.4 | 5.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 1.4 | 28.7 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 1.4 | 4.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 1.4 | 4.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 1.4 | 6.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 1.3 | 21.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 1.3 | 9.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 1.3 | 57.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 1.3 | 114.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 1.3 | 10.6 | GO:0043203 | axon hillock(GO:0043203) |
| 1.3 | 13.3 | GO:0000796 | condensin complex(GO:0000796) |
| 1.3 | 9.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 1.3 | 4.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.3 | 11.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.3 | 3.9 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 1.3 | 5.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 1.3 | 3.9 | GO:0000974 | Prp19 complex(GO:0000974) |
| 1.3 | 7.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 1.3 | 2.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 1.3 | 21.6 | GO:0042627 | chylomicron(GO:0042627) |
| 1.3 | 3.8 | GO:0031523 | Myb complex(GO:0031523) |
| 1.3 | 10.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 1.3 | 15.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 1.3 | 5.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 1.2 | 8.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 1.2 | 10.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 1.2 | 8.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 1.2 | 10.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 1.2 | 100.9 | GO:0005604 | basement membrane(GO:0005604) |
| 1.2 | 4.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 1.2 | 1.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 1.2 | 1.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 1.2 | 7.2 | GO:0005688 | U6 snRNP(GO:0005688) |
| 1.2 | 4.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 1.2 | 25.1 | GO:1990752 | microtubule end(GO:1990752) |
| 1.2 | 8.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 1.2 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
| 1.2 | 4.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 1.2 | 4.7 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.2 | 89.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 1.2 | 23.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 1.2 | 17.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 1.2 | 30.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 1.2 | 13.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 1.1 | 10.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 1.1 | 3.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 1.1 | 29.6 | GO:0031941 | filamentous actin(GO:0031941) |
| 1.1 | 14.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 1.1 | 5.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.1 | 7.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 1.1 | 5.6 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 1.1 | 12.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 1.1 | 3.3 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 1.1 | 12.8 | GO:0042555 | MCM complex(GO:0042555) |
| 1.1 | 4.3 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 1.1 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 1.1 | 11.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 1.0 | 7.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 1.0 | 26.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 1.0 | 9.3 | GO:0005955 | calcineurin complex(GO:0005955) |
| 1.0 | 12.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 1.0 | 3.1 | GO:0097441 | basilar dendrite(GO:0097441) |
| 1.0 | 5.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.0 | 23.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 1.0 | 4.1 | GO:0001740 | Barr body(GO:0001740) |
| 1.0 | 6.1 | GO:0051233 | spindle midzone(GO:0051233) |
| 1.0 | 27.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.0 | 15.8 | GO:0000812 | Swr1 complex(GO:0000812) |
| 1.0 | 7.8 | GO:0036452 | ESCRT complex(GO:0036452) |
| 1.0 | 4.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 1.0 | 5.8 | GO:0030677 | ribonuclease P complex(GO:0030677) |
| 0.9 | 2.8 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.9 | 3.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.9 | 5.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.9 | 19.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.9 | 11.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.9 | 0.9 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.9 | 1.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.9 | 6.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.9 | 6.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.9 | 9.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.8 | 4.2 | GO:0032021 | NELF complex(GO:0032021) |
| 0.8 | 3.4 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.8 | 20.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.8 | 5.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.8 | 42.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.8 | 26.1 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.8 | 9.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.8 | 0.8 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.8 | 8.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.8 | 2.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.8 | 17.5 | GO:0043034 | costamere(GO:0043034) |
| 0.8 | 7.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.8 | 12.5 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.8 | 4.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.8 | 5.5 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.8 | 7.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.8 | 2.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.8 | 10.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.8 | 3.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.8 | 3.8 | GO:0032449 | CBM complex(GO:0032449) |
| 0.8 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.8 | 1.5 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.8 | 35.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.8 | 0.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.8 | 2.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.8 | 5.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.7 | 3.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.7 | 3.0 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.7 | 5.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.7 | 2.2 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.7 | 4.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.7 | 1.5 | GO:0032982 | myosin filament(GO:0032982) |
| 0.7 | 3.7 | GO:0089701 | U2AF(GO:0089701) |
| 0.7 | 199.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.7 | 2.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.7 | 17.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.7 | 5.0 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.7 | 7.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.7 | 3.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.7 | 4.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.7 | 5.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.7 | 2.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.7 | 337.5 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
| 0.7 | 5.5 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.7 | 12.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.7 | 2.0 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.7 | 2.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.7 | 16.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.7 | 2.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.7 | 59.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.6 | 8.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.6 | 35.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.6 | 1.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.6 | 1.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.6 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.6 | 17.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.6 | 2.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.6 | 2.9 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.6 | 1.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.6 | 5.2 | GO:0033643 | host cell part(GO:0033643) |
| 0.6 | 3.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.6 | 1.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.6 | 2.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.6 | 2.3 | GO:0016234 | inclusion body(GO:0016234) |
| 0.6 | 2.8 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.6 | 70.5 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.5 | 7.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.5 | 22.3 | GO:0005912 | adherens junction(GO:0005912) |
| 0.5 | 6.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.5 | 1.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.5 | 1.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.5 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.5 | 6.7 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
| 0.5 | 10.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.5 | 9.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.5 | 8.1 | GO:0042599 | lamellar body(GO:0042599) |
| 0.5 | 9.1 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.5 | 7.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.5 | 9.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.5 | 4.0 | GO:0030478 | actin cap(GO:0030478) |
| 0.5 | 9.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.5 | 1.9 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.5 | 2.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.5 | 3.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 0.5 | 0.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.5 | 1.8 | GO:0045120 | pronucleus(GO:0045120) |
| 0.5 | 124.5 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.5 | 15.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.4 | 5.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.4 | 10.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.4 | 3.1 | GO:0071203 | WASH complex(GO:0071203) |
| 0.4 | 1.3 | GO:0022624 | proteasome accessory complex(GO:0022624) |
| 0.4 | 15.8 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.4 | 0.9 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.4 | 1.3 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.4 | 1.2 | GO:0060187 | cell pole(GO:0060187) |
| 0.4 | 2.5 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
| 0.4 | 2.4 | GO:0097546 | ciliary base(GO:0097546) |
| 0.4 | 5.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.4 | 42.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.4 | 27.4 | GO:0005901 | caveola(GO:0005901) |
| 0.4 | 13.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.4 | 0.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.4 | 6.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.4 | 2.3 | GO:0005884 | actin filament(GO:0005884) |
| 0.4 | 3.0 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.4 | 1.9 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.4 | 5.9 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.4 | 5.9 | GO:0070161 | anchoring junction(GO:0070161) |
| 0.4 | 6.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.4 | 8.7 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.3 | 107.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.3 | 11.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.3 | 1.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.3 | 17.8 | GO:0005811 | lipid particle(GO:0005811) |
| 0.3 | 2.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.3 | 1.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.3 | 1.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.3 | 2.9 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.3 | 29.3 | GO:0030496 | midbody(GO:0030496) |
| 0.3 | 3.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.3 | 33.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.3 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.3 | 5.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.3 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.3 | 3.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.3 | 13.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.3 | 2.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 2.9 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.3 | 14.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.3 | 1.4 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.3 | 8.7 | GO:0005903 | brush border(GO:0005903) |
| 0.3 | 2.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.3 | 9.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.3 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.3 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.3 | 2.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 560.6 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.3 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 10.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.2 | 13.0 | GO:0005840 | ribosome(GO:0005840) |
| 0.2 | 2.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 1.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.2 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
| 0.2 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.2 | 2.2 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 2.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.2 | 4.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.2 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 1.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.2 | 1.2 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.2 | 0.8 | GO:0097433 | dense body(GO:0097433) |
| 0.2 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 63.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.2 | 6.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 2.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) junctional membrane complex(GO:0030314) |
| 0.1 | 0.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 2.4 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.1 | 0.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 2.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 1.9 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 2.2 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.1 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 4.2 | GO:0005938 | cell cortex(GO:0005938) |
| 0.1 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 1.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 1.7 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.9 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.0 | 33.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
| 0.0 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.9 | 55.6 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 11.2 | 44.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 10.3 | 30.8 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 9.6 | 67.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 9.0 | 44.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 8.8 | 44.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 6.7 | 20.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 5.7 | 28.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 5.7 | 45.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 5.1 | 10.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 5.0 | 20.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 4.9 | 19.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 4.9 | 14.7 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 4.8 | 24.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 4.8 | 19.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 4.6 | 18.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 4.6 | 13.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 4.5 | 26.8 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 4.4 | 30.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 4.4 | 17.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 4.2 | 16.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 4.1 | 16.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 4.1 | 28.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 4.0 | 11.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 4.0 | 11.9 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 4.0 | 11.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 4.0 | 79.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 4.0 | 23.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 3.9 | 63.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 3.9 | 55.1 | GO:0031014 | troponin T binding(GO:0031014) |
| 3.9 | 15.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 3.9 | 34.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 3.8 | 46.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 3.7 | 11.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 3.7 | 11.0 | GO:0030984 | kininogen binding(GO:0030984) |
| 3.6 | 40.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 3.6 | 98.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 3.6 | 18.0 | GO:0070404 | NADH binding(GO:0070404) |
| 3.6 | 14.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 3.6 | 17.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 3.5 | 24.8 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 3.5 | 14.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 3.5 | 14.1 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 3.4 | 10.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 3.4 | 10.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 3.4 | 10.1 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 3.4 | 10.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 3.3 | 16.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 3.3 | 16.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 3.3 | 20.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 3.2 | 9.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 3.2 | 19.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 3.1 | 9.3 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 3.1 | 21.5 | GO:0005497 | androgen binding(GO:0005497) |
| 3.0 | 30.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 3.0 | 3.0 | GO:0019239 | deaminase activity(GO:0019239) |
| 3.0 | 8.9 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 3.0 | 20.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 2.9 | 8.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 2.9 | 20.6 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 2.9 | 35.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 2.9 | 8.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 2.9 | 8.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 2.9 | 17.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 2.9 | 14.4 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 2.8 | 2.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 2.8 | 50.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 2.8 | 16.9 | GO:0047115 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 2.8 | 8.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 2.8 | 8.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 2.8 | 8.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 2.8 | 33.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 2.7 | 21.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 2.7 | 21.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 2.7 | 16.0 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 2.6 | 29.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 2.6 | 264.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 2.6 | 31.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 2.6 | 10.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 2.6 | 15.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 2.6 | 5.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 2.6 | 10.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 2.6 | 18.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 2.6 | 74.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 2.5 | 7.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 2.5 | 22.8 | GO:0015288 | porin activity(GO:0015288) |
| 2.5 | 27.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 2.5 | 19.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 2.4 | 14.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 2.4 | 128.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 2.4 | 16.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 2.4 | 78.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 2.4 | 68.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 2.4 | 16.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 2.4 | 7.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 2.3 | 7.0 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 2.3 | 7.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 2.3 | 9.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 2.3 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 2.3 | 9.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 2.3 | 18.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 2.3 | 9.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 2.3 | 15.9 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 2.3 | 11.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 2.3 | 2.3 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
| 2.3 | 6.8 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 2.2 | 2.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 2.2 | 6.6 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 2.2 | 15.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 2.2 | 6.5 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 2.1 | 2.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 2.1 | 6.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 2.1 | 10.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 2.1 | 8.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 2.1 | 10.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 2.0 | 10.1 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 2.0 | 6.1 | GO:0048030 | disaccharide binding(GO:0048030) |
| 2.0 | 6.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 2.0 | 91.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 2.0 | 8.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 2.0 | 29.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 2.0 | 29.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 2.0 | 7.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 2.0 | 7.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 2.0 | 15.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 2.0 | 17.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 2.0 | 7.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 1.9 | 7.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 1.9 | 11.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 1.9 | 7.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 1.9 | 17.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.9 | 9.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 1.9 | 9.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.9 | 26.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 1.9 | 34.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.9 | 7.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 1.9 | 7.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 1.9 | 7.5 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 1.9 | 1.9 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 1.9 | 52.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 1.9 | 16.7 | GO:0032190 | acrosin binding(GO:0032190) |
| 1.8 | 7.3 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 1.8 | 5.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 1.8 | 16.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 1.8 | 12.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.8 | 9.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 1.8 | 14.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 1.8 | 39.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 1.8 | 3.6 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 1.8 | 5.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.8 | 10.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.8 | 19.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 1.8 | 12.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 1.8 | 38.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 1.7 | 8.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.7 | 7.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 1.7 | 6.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 1.7 | 17.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 1.7 | 18.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 1.7 | 8.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 1.7 | 30.6 | GO:0031402 | sodium ion binding(GO:0031402) |
| 1.7 | 6.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.7 | 13.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 1.7 | 6.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 1.7 | 5.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.7 | 20.0 | GO:0043295 | glutathione binding(GO:0043295) |
| 1.7 | 6.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 1.6 | 18.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.6 | 4.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 1.6 | 17.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 1.6 | 11.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.6 | 15.7 | GO:0031386 | protein tag(GO:0031386) |
| 1.6 | 7.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 1.6 | 9.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 1.5 | 1.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 1.5 | 12.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 1.5 | 3.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.5 | 4.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.5 | 1.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 1.5 | 7.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.5 | 12.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 1.5 | 7.4 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 1.5 | 8.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.5 | 7.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 1.5 | 13.2 | GO:0035877 | death effector domain binding(GO:0035877) |
| 1.5 | 5.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 1.5 | 17.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 1.5 | 4.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 1.5 | 4.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 1.4 | 2.9 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 1.4 | 17.4 | GO:0001968 | fibronectin binding(GO:0001968) |
| 1.4 | 4.3 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 1.4 | 2.9 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 1.4 | 10.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 1.4 | 25.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 1.4 | 7.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 1.4 | 14.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 1.4 | 7.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 1.4 | 18.4 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.4 | 15.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 1.4 | 4.2 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 1.4 | 7.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 1.4 | 51.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 1.4 | 5.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 1.4 | 6.9 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 1.4 | 1.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 1.4 | 4.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 1.4 | 10.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 1.4 | 4.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 1.3 | 5.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 1.3 | 26.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 1.3 | 8.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.3 | 4.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 1.3 | 3.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 1.3 | 35.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 1.3 | 3.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.3 | 5.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 1.3 | 6.5 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 1.3 | 15.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 1.3 | 13.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 1.3 | 7.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 1.2 | 3.7 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.2 | 4.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 1.2 | 14.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.2 | 29.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 1.2 | 3.5 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 1.2 | 11.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 1.2 | 3.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 1.2 | 26.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 1.2 | 44.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 1.2 | 3.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 1.2 | 16.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 1.2 | 3.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 1.2 | 3.5 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
| 1.1 | 5.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 1.1 | 9.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 1.1 | 4.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.1 | 1.1 | GO:0070905 | serine binding(GO:0070905) |
| 1.1 | 46.9 | GO:0003785 | actin monomer binding(GO:0003785) |
| 1.1 | 4.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 1.1 | 17.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 1.1 | 2.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 1.1 | 49.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 1.1 | 2.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 1.1 | 23.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 1.1 | 22.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 1.1 | 4.5 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 1.1 | 6.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 1.1 | 12.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 1.1 | 36.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 1.1 | 7.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 1.1 | 3.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 1.1 | 4.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.1 | 3.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.1 | 24.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 1.1 | 17.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.1 | 2.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 1.1 | 3.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 1.1 | 4.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 1.0 | 7.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 1.0 | 17.7 | GO:0044548 | S100 protein binding(GO:0044548) |
| 1.0 | 2.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 1.0 | 1.0 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 1.0 | 138.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 1.0 | 3.1 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 1.0 | 6.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 1.0 | 4.1 | GO:0061134 | peptidase regulator activity(GO:0061134) |
| 1.0 | 6.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.0 | 3.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.0 | 5.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 1.0 | 25.1 | GO:0043236 | laminin binding(GO:0043236) |
| 1.0 | 10.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 1.0 | 3.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.0 | 5.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.0 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
| 1.0 | 5.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 1.0 | 6.8 | GO:0005534 | galactose binding(GO:0005534) |
| 1.0 | 2.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 1.0 | 5.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 1.0 | 2.9 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 1.0 | 21.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.9 | 190.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.9 | 7.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.9 | 5.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.9 | 0.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.9 | 0.9 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.9 | 8.3 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.9 | 4.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.9 | 3.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.9 | 341.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.9 | 2.7 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.9 | 4.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.9 | 18.0 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.9 | 5.4 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.9 | 3.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.9 | 2.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.9 | 82.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.9 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.9 | 15.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.9 | 8.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.9 | 1.7 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.9 | 3.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.9 | 6.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.9 | 127.4 | GO:0005178 | integrin binding(GO:0005178) |
| 0.9 | 1.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.8 | 2.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.8 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.8 | 5.1 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.8 | 4.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.8 | 5.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.8 | 6.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.8 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.8 | 2.5 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.8 | 4.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.8 | 3.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.8 | 6.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.8 | 3.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.8 | 3.2 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.8 | 7.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.8 | 7.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.8 | 10.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.8 | 7.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.8 | 5.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.8 | 1.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.8 | 4.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.8 | 10.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.8 | 4.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.8 | 6.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.8 | 9.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.8 | 6.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.7 | 2.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.7 | 3.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.7 | 2.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.7 | 3.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.7 | 31.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.7 | 3.6 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.7 | 2.2 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.7 | 2.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.7 | 7.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.7 | 3.5 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.7 | 10.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.7 | 2.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.7 | 11.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.7 | 5.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.7 | 4.1 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.7 | 6.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.7 | 2.7 | GO:0048185 | activin binding(GO:0048185) |
| 0.7 | 3.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.7 | 8.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.7 | 2.6 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.7 | 6.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.7 | 14.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.7 | 6.5 | GO:0071949 | FAD binding(GO:0071949) |
| 0.6 | 12.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.6 | 1.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.6 | 0.6 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.6 | 1.9 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.6 | 18.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.6 | 2.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.6 | 39.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.6 | 18.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.6 | 1.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.6 | 3.1 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.6 | 6.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.6 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.6 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.6 | 1.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.6 | 1.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 0.6 | 6.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.6 | 6.0 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.6 | 185.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.6 | 13.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.6 | 16.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.6 | 2.4 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.6 | 0.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.6 | 1.7 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.6 | 5.2 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.6 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.6 | 21.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.6 | 1.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.6 | 8.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.5 | 19.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.5 | 12.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.5 | 24.5 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.5 | 67.5 | GO:0008201 | heparin binding(GO:0008201) |
| 0.5 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.5 | 2.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.5 | 15.8 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.5 | 1.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.5 | 2.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.5 | 6.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.5 | 3.6 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.5 | 21.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.5 | 1.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.5 | 5.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.5 | 3.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.5 | 6.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.5 | 3.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.5 | 3.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.5 | 0.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.5 | 13.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.5 | 1.5 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.5 | 2.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.5 | 1.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.5 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.5 | 1.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.5 | 9.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.5 | 1.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.5 | 1.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.5 | 2.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.5 | 1.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.5 | 11.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.5 | 2.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.5 | 1.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.5 | 7.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.5 | 6.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.5 | 5.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.5 | 4.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.5 | 1.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.5 | 13.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.5 | 1.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.5 | 1.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.5 | 2.8 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.5 | 2.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.5 | 2.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.5 | 1.4 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.5 | 1.8 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.4 | 1.8 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.4 | 1.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.4 | 1.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.4 | 1.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.4 | 5.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.4 | 0.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.4 | 3.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.4 | 1.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.4 | 4.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 18.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.4 | 1.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.4 | 0.9 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.4 | 1.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.4 | 2.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 9.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.4 | 2.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.4 | 13.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.4 | 2.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.4 | 1.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.4 | 1.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.4 | 5.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.4 | 3.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.4 | 4.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.4 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 0.8 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.4 | 1.2 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.4 | 1.2 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.4 | 1.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.4 | 9.3 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.4 | 5.8 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 1.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.4 | 4.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.4 | 11.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.4 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.4 | 2.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.4 | 1.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.4 | 4.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.4 | 17.4 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.4 | 102.7 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.4 | 1.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.4 | 1.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.4 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.4 | 2.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.4 | 1.4 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.4 | 4.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.4 | 2.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.4 | 4.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.3 | 0.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.3 | 11.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.3 | 4.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.3 | 1.0 | GO:0045118 | azole transporter activity(GO:0045118) |
| 0.3 | 2.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.3 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.3 | 1.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.3 | 10.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.3 | 1.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.3 | 3.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.3 | 13.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.3 | 1.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 2.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.3 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.3 | 1.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 1.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.3 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.3 | 1.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.3 | 4.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.3 | 0.6 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.3 | 1.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.3 | 0.3 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.3 | 0.3 | GO:0016406 | carnitine O-palmitoyltransferase activity(GO:0004095) carnitine O-acyltransferase activity(GO:0016406) O-palmitoyltransferase activity(GO:0016416) |
| 0.3 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.3 | 2.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.3 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.3 | 24.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 0.9 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.3 | 12.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.3 | 5.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 4.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.3 | 8.0 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.3 | 1.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.3 | 8.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.3 | 9.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.3 | 2.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.3 | 2.3 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.3 | 0.3 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.3 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.3 | 0.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.3 | 3.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.3 | 4.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.3 | 3.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.3 | 2.4 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.3 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.3 | 3.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.2 | 1.0 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.2 | 0.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.2 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 1.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 1.9 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 1.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.2 | 2.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.2 | 3.3 | GO:0042805 | actinin binding(GO:0042805) |
| 0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 2.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 0.5 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.2 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.2 | 3.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 1.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.2 | 0.7 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.2 | 10.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.2 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.2 | 7.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.2 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.2 | 0.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.2 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.2 | 11.0 | GO:0005496 | steroid binding(GO:0005496) |
| 0.2 | 1.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.2 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 1.4 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.2 | 1.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 0.8 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.2 | 0.4 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
| 0.2 | 1.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.2 | 1.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 1.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.2 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.2 | 2.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 1.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 0.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 0.5 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.2 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 0.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.2 | 3.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 7.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.2 | 8.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.2 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 1.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 0.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.2 | 4.3 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.2 | 1.8 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.2 | 1.0 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.2 | 1.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.2 | 0.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.2 | 0.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.2 | 2.4 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 4.4 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.2 | 2.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 0.9 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.2 | 1.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.2 | 0.5 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.2 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 4.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.1 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 5.0 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 1.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.1 | 2.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 1.4 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 1.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 3.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.5 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.7 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 0.1 | GO:0017171 | serine hydrolase activity(GO:0017171) |
| 0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.1 | 0.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.1 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 0.3 | GO:0052827 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol pentakisphosphate phosphatase activity(GO:0052827) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.1 | 0.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.1 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 0.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 7.8 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.1 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 0.2 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 0.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
| 0.0 | 3.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.0 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.0 | 0.0 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.0 | 0.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 88.1 | PID ARF 3PATHWAY | Arf1 pathway |
| 3.0 | 69.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 2.6 | 36.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.9 | 95.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 1.9 | 64.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 1.6 | 110.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 1.6 | 4.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 1.6 | 97.6 | PID PLK1 PATHWAY | PLK1 signaling events |
| 1.6 | 63.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 1.5 | 59.9 | PID ALK1 PATHWAY | ALK1 signaling events |
| 1.5 | 41.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 1.4 | 79.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 1.4 | 23.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 1.4 | 4.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 1.3 | 89.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 1.2 | 2.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 1.1 | 21.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 1.1 | 33.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 1.1 | 31.6 | PID AURORA A PATHWAY | Aurora A signaling |
| 1.0 | 127.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 1.0 | 28.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.9 | 57.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.9 | 34.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.9 | 88.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.9 | 39.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.9 | 28.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.9 | 14.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.8 | 23.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.8 | 25.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.8 | 26.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.8 | 10.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.8 | 26.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.8 | 9.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.7 | 131.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.7 | 11.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.7 | 26.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.7 | 157.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.6 | 12.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.6 | 3.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.6 | 28.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.6 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.6 | 4.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.6 | 1.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.6 | 6.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.5 | 3.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.5 | 5.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.5 | 9.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.5 | 31.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.5 | 7.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.5 | 21.4 | PID BMP PATHWAY | BMP receptor signaling |
| 0.5 | 7.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.5 | 44.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.5 | 8.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.5 | 8.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.4 | 21.5 | PID P73PATHWAY | p73 transcription factor network |
| 0.4 | 6.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.4 | 23.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.4 | 27.2 | PID E2F PATHWAY | E2F transcription factor network |
| 0.4 | 4.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.4 | 4.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.4 | 13.4 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.4 | 8.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.4 | 15.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.4 | 22.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.4 | 9.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.4 | 4.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.4 | 3.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.4 | 19.1 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.4 | 14.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.4 | 10.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.4 | 5.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.4 | 6.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.4 | 1.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.4 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.4 | 9.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.3 | 10.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.3 | 9.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.3 | 22.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.3 | 1.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.3 | 23.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.3 | 10.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.3 | 5.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.3 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.3 | 3.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 9.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 8.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 15.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.2 | 11.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.2 | 1.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 6.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 3.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.2 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 4.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.2 | 3.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 10.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 33.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 2.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 2.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 1.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 1.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 1.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 1.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 2.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 261.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 3.9 | 58.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 3.6 | 122.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 3.2 | 29.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 2.6 | 49.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 2.6 | 57.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 2.5 | 99.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 2.4 | 58.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 2.4 | 45.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 2.3 | 199.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 2.3 | 52.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 2.2 | 4.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 2.2 | 56.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 2.2 | 30.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 2.0 | 40.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 1.9 | 51.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 1.8 | 16.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 1.8 | 49.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 1.8 | 38.4 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 1.8 | 140.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 1.8 | 116.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 1.8 | 19.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 1.8 | 85.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 1.7 | 59.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 1.7 | 42.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 1.7 | 1.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 1.7 | 13.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.6 | 34.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 1.6 | 64.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 1.6 | 9.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 1.6 | 25.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 1.6 | 142.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 1.6 | 11.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 1.5 | 16.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.5 | 22.7 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 1.5 | 56.1 | REACTOME S PHASE | Genes involved in S Phase |
| 1.5 | 21.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 1.5 | 26.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 1.4 | 36.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 1.4 | 201.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 1.4 | 25.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.4 | 32.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 1.4 | 28.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 1.4 | 29.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 1.3 | 48.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 1.3 | 45.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 1.3 | 73.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 1.3 | 11.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 1.3 | 11.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 1.3 | 23.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 1.2 | 107.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 1.2 | 23.5 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 1.2 | 9.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.2 | 24.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 1.2 | 77.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 1.2 | 35.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 1.2 | 5.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 1.1 | 6.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 1.1 | 47.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 1.1 | 3.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 1.0 | 52.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 1.0 | 23.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 1.0 | 9.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.0 | 50.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 1.0 | 18.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 1.0 | 10.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.9 | 10.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.9 | 23.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.9 | 22.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.9 | 45.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.9 | 13.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.8 | 29.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.8 | 12.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.8 | 14.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.8 | 8.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.8 | 1.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.8 | 11.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.8 | 17.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.8 | 12.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.8 | 7.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.8 | 10.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.8 | 3.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.8 | 36.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.7 | 3.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.7 | 3.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.7 | 11.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.7 | 8.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.7 | 48.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.7 | 15.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.7 | 16.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.7 | 3.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.6 | 12.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.6 | 20.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.6 | 5.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.6 | 7.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.6 | 20.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.6 | 11.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.6 | 10.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.6 | 12.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.6 | 6.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.6 | 11.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.6 | 9.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.6 | 9.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.6 | 5.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.6 | 16.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.6 | 33.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.5 | 58.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.5 | 37.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.5 | 18.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.5 | 8.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.5 | 20.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.5 | 1.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.5 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.5 | 8.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.5 | 12.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.5 | 33.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.5 | 5.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.4 | 9.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.4 | 16.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.4 | 2.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.4 | 5.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.4 | 1.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.4 | 7.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.4 | 6.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.3 | 45.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.3 | 3.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.3 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.3 | 15.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.3 | 44.7 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.3 | 6.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.3 | 2.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.3 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 0.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.3 | 7.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.3 | 1.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.3 | 1.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.3 | 1.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.3 | 25.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.2 | 7.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 4.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.2 | 2.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.2 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 9.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 26.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 5.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 7.2 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
| 0.2 | 0.8 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
| 0.2 | 2.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.2 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.2 | 7.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.2 | 5.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.2 | 2.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.2 | 9.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 2.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 1.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 0.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 3.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 5.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 1.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 2.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 5.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 2.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 0.3 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.0 | 1.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |